申请人:Hoffman-La Roche Inc.
公开号:US06307056B1
公开(公告)日:2001-10-23
Disclosed are 4-aryloxindoles that inhibit or modulate protein kinases, in particular JNK protein kinases. These compounds and their pharmaceutically acceptable salts, and prodrugs of said compounds, are useful as anti-inflammatory agents, particularly useful in the treatment of rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing the foregoing compounds, as well as methods for the treatment and/or control of inflammation, particularly in the treatment or control of rheumatoid arthritis, using said compounds.
披露的是4-元氧杂吲哚类化合物,这些化合物可以抑制或调节蛋白激酶,特别是JNK蛋白激酶。这些化合物及其药用可接受的盐,以及这些化合物的前药,作为抗炎剂特别有用,尤其是在治疗类风湿性关节炎方面。还披露了包含上述化合物的药物组合物,以及使用这些化合物治疗和/或控制炎症的方法,特别是在治疗或控制类风湿性关节炎方面。